Medically Tailored Meals Are Saving Costs in 49 States
By Elana Gotkine HealthDay Reporter
FRIDAY, April 11, 2025 -- Medically tailored meals (MTMs) are net cost-saving in the first year in 49 states, assuming full uptake among eligible patients with diet-related diseases and limitations in activities of daily living, according to a study published in the April issue of Health Affairs.
Using a population-based, open-cohort simulation model, Shuyue Deng, from Tufts University in Boston, and colleagues estimated state-specific one-year and five-year changes in annual hospitalizations, health care spending, and cost-effectiveness of MTMs for patients with diet-related diseases and limitations in activities of daily living who were covered by Medicaid, Medicare, or private insurance.
The researchers found that MTMs were net cost-saving in the first year in 49 states assuming full uptake among eligible people, with the largest savings seen in Connecticut ($6,299 per patient). Alabama was the exception, where MTMs were cost-neutral. To avert one hospitalization, the number of treated patients varied from 2.3 in Maryland to 6.9 in Colorado.
"The most striking finding is that medically tailored meals, assuming full uptake by eligible individuals, were cost-saving in 49 of 50 states, highlighting their potential to reduce both financial and health burdens," Deng said in a statement. "These results emphasize the potential for policymakers to integrate medically tailored meals into health care coverage at scale."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.